Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study

dc.authoridOzturk, Banu/0000-0003-0290-8787
dc.authoridSEZER, AHMET/0000-0002-6445-1439
dc.authoridSevinç, Alper/0000-0002-0499-8918
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridharputluoglu, hakan/0000-0001-8537-5941
dc.authoridTurna, Hande/0000-0003-0558-9371
dc.authoridElkıran, Emin Tamer/0000-0001-6681-7249
dc.authorwosidOzturk, Banu/AAD-4358-2019
dc.authorwosidSEZER, AHMET/AAD-2667-2020
dc.authorwosidTURHAL, NAZIM SERDAR/AAJ-4421-2020
dc.authorwosidSaglam, Esra Kaytan/AAE-7436-2020
dc.authorwosidSevinç, Alper/KPA-4519-2024
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidCoşkun, Hasan Şenol/C-2070-2016
dc.contributor.authorAbali, Huseyin
dc.contributor.authorCelik, Ismail
dc.contributor.authorKaraca, Burcak
dc.contributor.authorTurna, Hande
dc.contributor.authorSaglam, Esra Kaytan
dc.contributor.authorAkman, Tuelay
dc.contributor.authorOztop, Ilhan
dc.date.accessioned2024-08-04T20:41:16Z
dc.date.available2024-08-04T20:41:16Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPurpose: To develop a large Turkish National Melanoma registry in order to define demographic and clinicopathologic characteristics of patients with melanoma. Methods: The data was collected from 1635 patients with melanoma through a web-based registry system in 22 centers. Herein we present the results of 1157 patients with cutaneous melanoma. Results: The patient median age was 56.4 years and 646 (55.8%) were males. The commonest subtype was superficial spreading type (357, 30.9%). The commonest primary site was the lower extremities (N=353, 30.5%). The most common Breslow thickness was 1-2 mm (361 patients, 43.5%). Only 104 (12.5%) patients had a thickness <1mm. Among 694 patients with available data, 136 (19.6%) presented with stage 4 disease while the most frequent stage was stage 3, encountered in 393 (56.6% patients). Conclusion: Our melanoma registry is the largest in our country providing a snapshot view of cutaneous melanoma and its care. Our patients presented with more advanced stages and they had worse prognosis compared to SEER database.en_US
dc.description.sponsorshipBristol Myers Squiben_US
dc.description.sponsorshipThe authors declare that they received financial support from Bristol Myers Squib for data collection and statistical analyses.en_US
dc.identifier.endpage1141en_US
dc.identifier.issn1107-0625
dc.identifier.issn2241-6293
dc.identifier.issue4en_US
dc.identifier.pmid26416068en_US
dc.identifier.scopus2-s2.0-84943233086en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1137en_US
dc.identifier.urihttps://hdl.handle.net/11616/97002
dc.identifier.volume20en_US
dc.identifier.wosWOS:000361421900028en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherImprimatur Publicationsen_US
dc.relation.ispartofJournal of Buonen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectclinical featuresen_US
dc.subjectcutaneous melanomaen_US
dc.subjectpathologyen_US
dc.subjectregistryen_US
dc.subjectstagingen_US
dc.subjectTurkeyen_US
dc.titleCutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Studyen_US
dc.typeArticleen_US

Dosyalar